Skip to main content
AAN.com
Articles
August 22, 2005

The AD8
A brief informant interview to detect dementia

August 23, 2005 issue
65 (4) 559-564

Abstract

Background: Brief measures that accurately discriminate normal cognitive aging from very mild dementia are lacking. Cognitive tests often are insensitive to very mild dementia. Informant-based measures may be more sensitive in detecting early dementia.
Objective: To identify informant-reported clinical variables that differentiate cognitively normal individuals from those with very mild dementia.
Methods: A 55-item battery of informant queries regarding an individual's cognitive status was derived from a semistructured interview and a consensus panel of dementia experts. The battery was evaluated with informants for 189 consecutive participants of a longitudinal study of memory and aging and compared with an independently obtained Clinical Dementia Rating (CDR) score for the participant. Multiple regression and receiver operator characteristic curves assessed subsets of the items to discriminate between CDR 0 (no dementia) and CDR 0.5 (very mild dementia).
Results: The final version (AD8) querying memory, orientation, judgment, and function was administered to an additional sample of 112 CDR 0 and 68 CDR 0.5 participants. Using a cut-off of two items endorsed, the area under the curve was 0.834, suggesting good to excellent discrimination, sensitivity was 74%, and specificity was 86% (prevalence of 0.38 for very mild dementia). Inclusion of 56 additional individuals with mild to severe dementia (increasing dementia prevalence to 0.53) increased sensitivity to 85%.
Conclusions: The AD8 is a brief, sensitive measure that reliably differentiates between nondemented and demented individuals. Use of the AD8 in conjunction with a brief assessment of the participant could improve diagnostic accuracy in general practice.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (e1.doc)

References

1.
Boise L, Camicioli R, Morgan DL, Rose JH, Congleton L. Diagnosing dementia: perspectives of primary care physicians. Gerontologist 1999;39:457–465.
2.
Boise L, Neal MB, Kaye J. Dementia assessment in primary care: results from a study in three managed care systems. J Gerontol 2004;59:M621–M626.
3.
Meuser TM, Boise L, Morris J. C. Clinician beliefs and practices in dementia care: implications for health educators. Ed Gerontol 2004;30:491–516.
4.
Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinicians. J Psychiatr Res 1975;12:189–198.
5.
Lawrence J, Davidoff D, Katt-Lloyd D, Auerbach M, Hennen J. A pilot program of improved methods for community-based screening for dementia. Am J Geriatr Psychiatry 2001;9:205–211.
6.
Espino DV, Lichtenstein MJ, Palmer RF, Hazuda HP. Evaluation of the Mini-Mental State Examination's internal consistency in a community-based sample of Mexican-American and European-American elders: results from the San Antonio Longitudinal Study of Aging. J Am Geriatr Soc 2004;52:822–827.
7.
Lorentz W, Scanlan J, Borson S. Brief screening tests for dementia. Can J Psychiatry 2002;47:723–733.
8.
Fujii D, Hishinuma E, Masaki K, Petrovich H, Ross GW, White L. Dementia screening: can a second administration reduce the number of false positives? Am J Geriatr Psychiatry 2003;11:462–465.
9.
Brodaty H, Pond D, Kemp NM, et al. The GPCOG: a new screening test for dementia designed for general practice. J Am Geriatr Soc 2002;50:530–534.
10.
Katzman R, Brown T, Fuld P, et al. Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry 1983;140:734–739.
11.
Kuslansky G, Buschke H, Katz M, Sliwinski M, Lipton RB. Screening for Alzheimer's disease: the memory impairment screen versus the conventional three-word memory test. J Am Geriatr Soc 2002;50:1086–1091.
12.
Powlishta KK, Von Dras DD, Stanford A, et al. The clock drawing test is a poor screen for very mild dementia. Neurology 2002;59:898–903.
13.
Yamamoto S, Mogi N, Umegaki H, et al. The clock drawing test as a valid screening method for mild cognitive impairment. Dem Geriatr Cogn Disord 2004;18:172–179.
14.
Maeshima S, Osawa A, Maeshima E, et al. Usefulness of a cube-copying test in outpatients with dementia. Brain Inj 2004;18:889–898.
15.
Storey JE, Rowland JT, Conforti DA, Dickson HG. The Rowland Universal Dementia Assessment Scale (RUDAS): a multicultural cognitive assessment scale. Int Psychogeriatr 2004;16:13–31.
16.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939–944.
17.
Royall DR, Chiodo LK, Polk MJ. Misclassification is likely in the assessment of mild cognitive impairment. Neuroepidemiology 2004;23:185–191.
18.
Morris JC. The Clinical Dementia Rating (CDR)—current version and scoring rules. Neurology 1993;43:2412–2414.
19.
Jorm A, Christensen H, Korten A, Jacomb P, Henderson A. Informant ratings of cognitive decline in old age: validation against change on cognitive tests over 7 to 8 years. Psychol Med 2000;30:981–985.
20.
Morris JC, Berg L, Coben LA, Rubin EH, et al. Clinical Dementia Rating (CDR). In: Bergener M, Finkel SI, eds. Treating Alzheimer's and other dementias: clinical applications of recent research advances. New York: Springer, 1995:338–346.
21.
Tierney MC, Herrmann N, Geslani DM, Szalai JP. Contribution of informant and patient ratings to the accuracy of the Mini-Mental State Examination in predicting probable Alzheimer's disease. J Am Geriatr Soc 2003;51:813–818.
22.
Berg L, Hughes CP, Danziger WL, Martin RL, Knesevich J. Mild senile dementia of Alzheimer type (SDAT): research diagnostic criteria, recruitment, and description of a study population. J Neurol Neurosurg Psychiatry 1982;45:962–968.
23.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4 ed. Washington, DC: American Psychiatric Press, 1994.
24.
McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology 1996;47:1113–1124.
25.
Román GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250–260.
26.
Berg L, McKeel DW, Miller JP, et al. Clinicopathologic studies in cognitively healthy aging and Alzheimer disease—relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol 1998;55:326–335.
27.
Morris JC, Storandt M, Miller JP, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001;58:397–405.
28.
Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985–1992.
29.
Rockwood K, Strang D, MacKnight C, Downer R, Morris JC. Interrater reliability of the Clinical Dementia Rating in a multicenter trial. J Am Geriatr Soc 2000;48:558–559.
30.
Friis RH, Sellers TA. Epidemiology for public health practice. 2nd ed. Gaithersburg, MD: Aspen, 1999.
31.
Parker C, Philp I. Screening for cognitive impairment among older people in black and minority ethnic groups. Age Ageing 2004;33:447–452.
32.
Louis B, Harwood D, Hope T, Jacoby R. Can an informant questionnaire be used to predict the development of dementia in medical inpatients? Int J Geriatr Psychiatry 1999;14:941–945.
33.
Jorm A. The informant questionnaire on cognitive decline in the elderly: a review. Int Psychogeriatr 2004;16:275–293.
34.
Hopman-Rock M, Tak E, Staats P. Development and validation of the Observation List for Early Signs of Dementia (OLD). Int J Geriatr Psychiatry 2004;16:406–414.
35.
Carr DB, Gray S, Baty J, Morris JC. The value of informant vs. individual's complaints of memory impairment in early dementia. Neurology 2000;55:1724–1726.
36.
Cacchione PZ, Powlishta KK, Grant EA, Buckles VD, Morris JC. Accuracy of collateral source reports in very mild to mild dementia of the Alzheimer type. J Am Geriatr Soc 2003;51:819–823.
37.
Ready R, Ott B, Grace J. Validity of informant reports about AD and MCI patients' memory. Alzheimer Dis 2004;18:11–16.

Information & Authors

Information

Published In

Neurology®
Volume 65Number 4August 23, 2005
Pages: 559-564
PubMed: 16116116

Publication History

Published online: August 22, 2005
Published in print: August 23, 2005

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

J. E. Galvin, MD, MPH
From the Departments of Neurology (Drs. Galvin and Morris, M.A. Coats and S.J. Muich), Anatomy and Neurobiology (Dr. Galvin), Psychology (Drs. Powlishta and Storandt), and Pathology and Immunology (Dr. Morris) and Division of Biostatistics (Drs. Roe, Grant, and J.P. Miller) and Alzheimer's Disease Research Center, Washington University, St. Louis, MO.
C. M. Roe, PhD
From the Departments of Neurology (Drs. Galvin and Morris, M.A. Coats and S.J. Muich), Anatomy and Neurobiology (Dr. Galvin), Psychology (Drs. Powlishta and Storandt), and Pathology and Immunology (Dr. Morris) and Division of Biostatistics (Drs. Roe, Grant, and J.P. Miller) and Alzheimer's Disease Research Center, Washington University, St. Louis, MO.
K. K. Powlishta, PhD
From the Departments of Neurology (Drs. Galvin and Morris, M.A. Coats and S.J. Muich), Anatomy and Neurobiology (Dr. Galvin), Psychology (Drs. Powlishta and Storandt), and Pathology and Immunology (Dr. Morris) and Division of Biostatistics (Drs. Roe, Grant, and J.P. Miller) and Alzheimer's Disease Research Center, Washington University, St. Louis, MO.
M. A. Coats, RN, MSN
From the Departments of Neurology (Drs. Galvin and Morris, M.A. Coats and S.J. Muich), Anatomy and Neurobiology (Dr. Galvin), Psychology (Drs. Powlishta and Storandt), and Pathology and Immunology (Dr. Morris) and Division of Biostatistics (Drs. Roe, Grant, and J.P. Miller) and Alzheimer's Disease Research Center, Washington University, St. Louis, MO.
S. J. Muich, RN, MSN
From the Departments of Neurology (Drs. Galvin and Morris, M.A. Coats and S.J. Muich), Anatomy and Neurobiology (Dr. Galvin), Psychology (Drs. Powlishta and Storandt), and Pathology and Immunology (Dr. Morris) and Division of Biostatistics (Drs. Roe, Grant, and J.P. Miller) and Alzheimer's Disease Research Center, Washington University, St. Louis, MO.
E. Grant, PhD
From the Departments of Neurology (Drs. Galvin and Morris, M.A. Coats and S.J. Muich), Anatomy and Neurobiology (Dr. Galvin), Psychology (Drs. Powlishta and Storandt), and Pathology and Immunology (Dr. Morris) and Division of Biostatistics (Drs. Roe, Grant, and J.P. Miller) and Alzheimer's Disease Research Center, Washington University, St. Louis, MO.
J. P. Miller
From the Departments of Neurology (Drs. Galvin and Morris, M.A. Coats and S.J. Muich), Anatomy and Neurobiology (Dr. Galvin), Psychology (Drs. Powlishta and Storandt), and Pathology and Immunology (Dr. Morris) and Division of Biostatistics (Drs. Roe, Grant, and J.P. Miller) and Alzheimer's Disease Research Center, Washington University, St. Louis, MO.
M. Storandt, PhD
From the Departments of Neurology (Drs. Galvin and Morris, M.A. Coats and S.J. Muich), Anatomy and Neurobiology (Dr. Galvin), Psychology (Drs. Powlishta and Storandt), and Pathology and Immunology (Dr. Morris) and Division of Biostatistics (Drs. Roe, Grant, and J.P. Miller) and Alzheimer's Disease Research Center, Washington University, St. Louis, MO.
J. C. Morris, MD
From the Departments of Neurology (Drs. Galvin and Morris, M.A. Coats and S.J. Muich), Anatomy and Neurobiology (Dr. Galvin), Psychology (Drs. Powlishta and Storandt), and Pathology and Immunology (Dr. Morris) and Division of Biostatistics (Drs. Roe, Grant, and J.P. Miller) and Alzheimer's Disease Research Center, Washington University, St. Louis, MO.

Notes

Address correspondence and reprint requests to Dr Galvin, Alzheimer Disease Research Center, Washington University School of Medicine, 4488 Forest Park, Suite 130, St. Louis, MO 63108; e-mail: [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. From physical activity patterns to cognitive status: development and validation of novel digital biomarkers for cognitive assessment in older adults, International Journal of Behavioral Nutrition and Physical Activity, 22, 1, (2025).https://doi.org/10.1186/s12966-025-01706-x
    Crossref
  2. The influencing factors of cognitive impairment in elderly individuals in Chengdu city: a cross-sectional study based on AD8, BMC Geriatrics, 25, 1, (2025).https://doi.org/10.1186/s12877-024-05661-3
    Crossref
  3. Frailty as a mediator between sleep quality and cognitive impairment among the rural older adults: a cross-sectional study, BMC Geriatrics, 25, 1, (2025).https://doi.org/10.1186/s12877-024-05657-z
    Crossref
  4. Do Amyloid Cerebral Deposits Influence the Long-Term Poststroke Cognitive Outcome?: The IDEA3 Study, Stroke, 56, 1, (74-83), (2025).https://doi.org/10.1161/STROKEAHA.124.049147
    Crossref
  5. Maternal differential treatment and adult children's well‐being when mothers have cognitive impairment, Journal of Marriage and Family, (2025).https://doi.org/10.1111/jomf.13069
    Crossref
  6. An overview of the genes and biomarkers in Alzheimer’s disease, Ageing Research Reviews, 104, (102599), (2025).https://doi.org/10.1016/j.arr.2024.102599
    Crossref
  7. Hospitalization outcomes among older adults living undiagnosed or unaware of dementia, Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 17, 1, (2025).https://doi.org/10.1002/dad2.70051
    Crossref
  8. Canadian Stroke Best Practice Recommendations: Vascular cognitive impairment, 7th edition practice guidelines update, 2024, Alzheimer's & Dementia, (2025).https://doi.org/10.1002/alz.14324
    Crossref
  9. Dementia, Annals of Internal Medicine, 177, 11, (ITC161-ITC176), (2024).https://doi.org/10.7326/ANNALS-24-02207
    Crossref
  10. The Effect of the “Safety in Dementia” Online Tool to Assist Decision Making for Caregivers of Persons With Dementia and Access to Firearms, Annals of Internal Medicine, 177, 12, (1630-1640), (2024).https://doi.org/10.7326/ANNALS-24-00763
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Figures

Tables

Media

Share

Share

Share article link

Share